Blood And Blood Components Market
According to a new study by DataHorizzon Research, the “Blood And Blood Components Market” is projected to grow at a CAGR of 4.8% from 2025 to 2033, driven by rising transfusion needs, expanding trauma cases, increasing surgical procedures, and accelerated adoption of advanced blood processing and storage technologies.
Market Size & Insights
The blood and blood components market is valued at approximately USD 25 billion in 2024 and is anticipated to reach around USD 40 billion by 2033, reflecting a CAGR of 4.8% from 2025 to 2033.
The blood and blood components market has evolved into a critical pillar of global healthcare infrastructure, supporting procedures across trauma care, oncology, transplant medicine, and chronic disease management. With increasing global healthcare spending, improved diagnostic rates, and a growing elderly population, demand for blood components such as red blood cells, platelets, plasma, and cryoprecipitate continues to strengthen.
Red blood cells account for the largest share due to rising surgical volumes and emergency care utilization, while platelet demand is intensifying due to increased prevalence of hematological disorders and aggressive cancer therapies. Technological advancements-particularly automated blood collection systems, pathogen reduction technologies, and improved fractionation methods-are enhancing both efficiency and safety. Additionally, growing awareness of voluntary blood donation programs and government-led campaigns in developing economies is widening the supply pool. As healthcare systems modernize, demand for safe, high-quality, and well-processed blood components is expected to soar during 2025-2033.
Get a free sample report: https://datahorizzonresearch.com/request-sample-pdf/blood-and-blood-components-market-47307
Important Points
• Increasing adoption of automated collection and apheresis technologies is improving yield efficiency and product safety.
• Rising global surgical volume directly boosts demand for red cell concentrates and plasma derivatives.
• Hematological and oncological treatments remain the strongest drivers of platelet consumption worldwide.
• Government-supported donation campaigns are expanding blood availability across emerging economies.
• Technological breakthroughs in pathogen reduction and cold-chain logistics enhance product quality and lifespan.
• Growing demand for plasma-derived therapeutics is elevating the significance of plasma fractionation facilities.
Key Factors Driving the Future Growth of the Blood And Blood Components Market
• Rising incidence of trauma, accidents, and emergency medical conditions requiring immediate transfusions.
• Expansion of oncology treatments and stem cell transplants that heavily rely on platelet and plasma transfusions.
• Advancements in blood processing equipment, including automated centrifugation and storage systems.
• Emergence of pathogen-reduction technologies to minimize infection and contamination risks.
• Increased investments in national blood banking infrastructure and donor mobilization initiatives.
Top 10 Market Companies
• Abbott Laboratories
• Fresenius Kabi
• Terumo BCT
• Haemonetics Corporation
• Grifols S.A.
• Bio-Rad Laboratories
• Macopharma
• Immucor Inc.
• Octapharma AG
• CSL Behring
Market Segments
By Component Type:
o Red Blood Cells
o Plasma
o Platelets
o White Blood Cells
By Application:
o Surgery
o Trauma Care
o Cancer Treatment
o Chronic Disease Management
o Others
By End-User:
o Blood Banks
o Hospitals
o Research Institutes
o Clinics
By Region:
o North America
o Europe
o Asia Pacific
o Latin America
o Middle East & Africa
Recent Developments
• Expansion of large-scale plasma collection centers by global biotechnology companies.
• Increased adoption of automated apheresis systems in emerging markets to enhance donor efficiency.
• Strategic collaborations among hospitals and independent blood banks to strengthen regional supply chains.
• Development of next-generation pathogen-reduction technologies for platelets and plasma.
• Government-backed campaigns promoting voluntary donation to reduce dependence on professional donors.
• Adoption of blockchain-based systems in some regions for secure blood inventory tracking and traceability.
Regional Insights
North America remains the dominant market due to advanced blood banking infrastructure, high awareness, and strong adoption of safety technologies. Europe benefits from stringent regulatory frameworks and rapidly growing plasma-derived therapeutics demand. Asia-Pacific is emerging as the fastest-growing region, supported by improving healthcare access, rising road-traffic injuries, and expanding hospital networks in China and India. Latin America is experiencing steady growth due to increasing donation campaigns and investments in public healthcare systems. The Middle East & Africa market is gradually expanding with government initiatives aimed at strengthening national blood transfusion services and improving storage and cold-chain systems.
Market Outlook
The global blood and blood components market is poised for sustained expansion through 2033 as healthcare systems sharply increase their focus on emergency preparedness, surgical care, and chronic disease management. With aging populations worldwide, the need for transfusions related to cardiovascular disease, cancer therapy, and organ transplants is expected to rise. At the same time, advancements in collection, separation, and preservation technologies will greatly improve supply efficiency and product quality.
Growing reliance on plasma-derived biologics-such as immunoglobulins and clotting factors-will significantly drive plasma collection volumes. Market players are expected to invest in expanding plasma fractionation capacity and securing reliable donor networks. Digital transformation of blood banks, including real-time inventory tracking and smart logistics, will further strengthen the supply chain.
The outlook also suggests increasing regionalization of blood systems, with emerging economies modernizing donation infrastructure and investing in mobile blood collection units. Overall, the market’s long-term growth trajectory remains strong, supported by rising global health needs, continuous innovation, and increasing integration of transfusion services within modern healthcare systems.
Contact:
Ajay N
Ph: +1-970-633-3460
Latest Reports:
Endoscope Reprocessing Market: https://datahorizzonresearch.com/endoscope-reprocessing-market-2553
Jaw Crusher Market: https://datahorizzonresearch.com/jaw-crusher-market-3237
Global Carbon Nanotube (CNT) Conductive Masterbatch Market: https://datahorizzonresearch.com/global-carbon-nanotube-cnt-conductive-masterbatch-market-48595
Cold Chain Transportation Market: https://datahorizzonresearch.com/cold-chain-transportation-market-49271
Company Name: DataHorizzon Research
Address: North Mason Street, Fort Collins,
Colorado, United States.
Mail: sales@datahorizzonresearch.com
DataHorizzon is a market research and advisory company that assists organizations across the globe in formulating growth strategies for changing business dynamics. Its offerings include consulting services across enterprises and business insights to make actionable decisions. DHR’s comprehensive research methodology for predicting long-term and sustainable trends in the market facilitates complex decisions for organizations.
This release was published on openPR.
